Developing the First Precision Immunotherapy
Learn about the NCI-funded research that enabled the first FDA approved precision medicine- the immune checkpoint inhibitor pembrolizumab.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1127139/syndication
- Syndication ID: 18393
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, December 19, 2018 at 06:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:41 PM
Embed Code Snippet
To get the embed code snippet please Login.
